| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +9.73% | +2.88% | +6.85% | +6.85% | — |
| 14d | 1 | +0.00% | +7.96% | +4.59% | +3.37% | +3.37% | — |
| 30d | 1 | +0.00% | +17.70% | +6.42% | +11.28% | +11.28% | — |
| 60d | 1 | +0.00% | +4.87% | +6.41% | -1.54% | -1.54% | — |
| 90d | 1 | +0.00% | +27.88% | +8.65% | +19.23% | +19.23% | — |
| 180d | 1 | +0.00% | +18.14% | +12.86% | +5.28% | +5.28% | — |
| 1y | 1 | +100.00% | -33.63% | +17.74% | -51.37% | -51.37% | — |
| 2y | 1 | +100.00% | -36.73% | +5.38% | -42.10% | -42.10% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASE Sr Director Finance/Controller | 6,000 | $0.69 | $4.2K | 6,000 | Mar 30, 2021 | Apr 1, 2021 ↗ |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE Sr Director Finance/Controller | 6,000 | $2.23 | $13.4K | 0 | Mar 30, 2021 | Apr 1, 2021 ↗ |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | SALE Sr Director Finance/Controller | 6,000 | — | — | 39,200 | Mar 30, 2021 | Apr 1, 2021 ↗ |
| LCTX LINEAGE CELL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,700 | — | — | 42,700 | Mar 15, 2021 | Apr 1, 2021 ↗ |